作者: Stephen B. Dunnett , Anders Björklund , Olle Lindvall
DOI: 10.1038/35072572
关键词: Parkinson's disease 、 Embryonic Tissue 、 Bioinformatics 、 Key issues 、 Disease 、 Cell replacement 、 Cell therapy 、 Medicine
摘要: The results of the first double-blind placebo-controlled trial using grafts embryonic tissue to treat Parkinson's disease have aroused widespread interest and debate about future cell replacement therapies. What are key issues that need be resolved directions in which this technology is likely develop?